Skip to main content

Cyclosporine News

Related terms: Cyclosporine Ophthalmic

Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children

TUESDAY, Sept. 26, 2023 – For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published...

FDA Approves Vevye (cyclosporine) Ophthalmic Solution for the Treatment of the Signs and Symptoms of Dry Eye Disease

Heidelberg, Germany and Cambridge, MA, USA, June 8, 2023 – Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that the U.S. Food and D...

FDA Approves Verkazia (cyclosporine ophthalmic emulsion) for the Treatment of Vernal Keratoconjunctivitis

EMERYVILLE, Calif.--(BUSINESS WIRE) June 24, 2021 --Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on eye care, today...

Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease

MUMBAI, India & PRINCETON, N.J.--(BUSINESS WIRE)-- August 16, 2018 – Sun Pharmaceutical Industries Ltd. (Reuters:SUN.BO, Bloomberg:SUNP IN, NSE:SUNPHARMA, BSE:524715, “Sun Pharma” and includes its su...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Eczema, Crohn's Disease, Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Psoriatic Arthritis, Inflammatory Bowel Disease

Cyclosporine patient information at Drugs.com